PepGen Inc.

NASDAQ:PEPG

Biotechnology

Healthcare
$3.83 +5.29%

+$0.09 today

Market cap
$265.27M
Beta
1.93
P/E (TTM)
-1.6
EPS (TTM)
-$1.12
52W Low $1.01High $7.80

Volume 3.39M

Average 1.37M

Returns on capital

PepGen Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-60.8%

avg -46.0%

ROIC

-56.9%

avg -43.1%

ROA

-51.6%

avg -38.1%

Analysis

ROA is currently the strongest return metric at -51.6% versus its period average of -38.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

James G. McArthur

President, Chief Executive Officer, Treasurer, Secretary & DirectorUSD 1.06M64296.33K0.43%

Noel Donnelly

Chief Financial OfficerUSD 742.6K56111.60K0.16%

Joseph D. Vittiglio

Chief Business & Legal Officer and SecretaryUSD 391.64K54——

Paul D. Streck

Executive Vice President and Head of Research & DevelopmentUSD 332.73K62——

Michael Zhao

Vice President & Head of Biometrics————

Hayley Parker

Senior Vice President of Global Regulatory Affairs & Quality————

Kasra Kasraian

Chief Technology Officer—5950.07K0.07%

Emiko Bryant

Senior Vice President of HR & Administration————

Melissa Michaels

Executive Director & Head of Regulatory Affairs CMC————

Pallavi Lonkar

Vice President & Head of Preclinical————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding May 21, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

7

$59,312.24

Net Transaction Value

−$59,312.24

Net selling

Most Active

STRECK PAUL

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
May 21, 26

Kasraian Kasra

Direct

Sell$1.7K
Mar 4, 26

STRECK PAUL

Direct

Sell$11.4K
Mar 4, 26

STRECK PAUL

Direct

Sell$295.5
Mar 4, 26

Donnelly Noel

Direct

Sell$12.7K
Mar 4, 26

Donnelly Noel

Direct

Sell$328.9
Mar 4, 26

McArthur James G

Direct

Sell$32K
Mar 4, 26

McArthur James G

Direct

Sell$828.6

Summary

Insiders reported 0 buys worth $0.00 and 7 sells worth $59,312.24 over the last 12 months. That adds up to net selling of $59,312.24. STRECK PAUL was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does PepGen Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about PEPG's management, answered from reported figures.

Who manages PEPG?

PepGen Inc. (PEPG) lists 10 active executives. The top listed executive is Paul D. Streck, Executive Vice President and Head of Research & Development.

Are PEPG insiders buying or selling?

Recent insider activity shows net buying of $140.43M.